Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans
    2.
    发明授权
    Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans 有权
    使用尼可地尔治疗性功能障碍或增强包括人类在内的哺乳动物的性功能

    公开(公告)号:US06214849B1

    公开(公告)日:2001-04-10

    申请号:US09326052

    申请日:1999-06-04

    IPC分类号: A61P1510

    CPC分类号: A61K31/455 Y10S514/906

    摘要: The present invention discloses the use of nicorandil in treatment of male impotency and female sexual dysfunction. Nitric ester of N-(2-hydroxyethyl) nicotinamide or nicorandil, as it is better known is known as a drug for treatment of circulatory diseases. It is a pyridine derivative. Several clinical tests performed on male patients suffering from impotency including severe penile erectile dysfunction or female patients suffering from female sexual arousal dysfunction consistently showed excellent results. There was not a single instance of any of side effects or other symptoms of toxicity or deaths due to myocardial infarctions as was the case with other drugs including pyrazolopyrimidones compounds.

    摘要翻译: 本发明公开了尼可地尔用于治疗男性阳ency和女性性功能障碍的用途。 已知N-(2-羟乙基)烟酰胺或尼可地尔的硝酸酯被称为用于治疗循环系统疾病的药物。 它是吡啶衍生物。 对男性患有严重阴茎勃起功能障碍的男性患者进行的几项临床测试或女性性唤起功能障碍的女性患者一贯表现出良好的效果。 没有任何副作用或其他由于心肌梗死引起的毒性或死亡症状的一例,其他药物包括吡唑并嘧啶化合物也是如此。

    Pharmaceutical composition useful for the treatment of hepatocellular carcinoma
    3.
    发明申请
    Pharmaceutical composition useful for the treatment of hepatocellular carcinoma 审中-公开
    用于治疗肝细胞癌的药物组合物

    公开(公告)号:US20060280817A1

    公开(公告)日:2006-12-14

    申请号:US11440790

    申请日:2006-05-25

    IPC分类号: A61K36/48

    CPC分类号: A61K36/48

    摘要: The present invention relates to anticancer activity against hepatocellular carcinoma of an extract and fraction isolated from flowers of Butea monosperma. Particularly, this invention relates to anticancer activity against hepatocellular carcinoma of a composition containing markered flavonoid glycosides such as butrin and isobutrin in the range of 2 to 9% by weight, isolated from the flowers of Butea monosperma by extracting the flowers with polar solvent like ethanol, methanol, aqueous ethanol or water, removing fatty non-polar constituents by triturating the extract with solvents such as ethylene chloride, methylene chloride, chloroform or ethyl acetate, suspending the residue in water, extracting with n-butanol and freeze drying the aqueous part.

    摘要翻译: 本发明涉及一种提取物对肝细胞癌的抗癌活性和从白花单倍体花中分离的部分。 特别地,本发明涉及通过用极性溶剂如乙醇提取鲜花,从含有白芍的花中分离出含有2至9重量%的标记的类黄酮苷类的标记黄酮糖苷类化合物的抗癌活性 ,甲醇,乙醇水溶液或水中,通过用溶剂如氯化乙烯,二氯甲烷,氯仿或乙酸乙酯研磨提取物除去脂肪非极性组分,将残余物悬浮在水中,用正丁醇萃取并冷冻干燥含水部分 。